Arbutus Biopharma

In News

Arbutus Biopharma Corporation (ABUS) Reports Q1 2026 Results - Yahoo Finance

Yahoo Finance - Jun 13, 2026

Arbutus Biopharma (ABUS) director awarded fully vested options on 78,800 shares - Stock Titan

Stock Titan - Jun 10, 2026

Arbutus Biopharma (ABUS) Edges Lower as Shares Trade Near Support Zone - Low Beta Factor - lwvtexas.org

lwvtexas.org - May 29, 2026

Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences - European AIDS Treatment Group

European AIDS Treatment Group - Apr 15, 2026

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna - GlobeNewswire

GlobeNewswire - Mar 03, 2026

Arbutus Biopharma Corporation (ABUS) Reports Q1 2026 Results - Insider Monkey

Insider Monkey - Jun 13, 2026

Arbutus Biopharma Corp ($ABUS) Former Interim President and CEO 2025 Pay Revealed - Quiver Quantitative

Quiver Quantitative - Apr 15, 2026

Arbutus Biopharma: A Fascinating HBV Story, But Still Too Early (NASDAQ:ABUS) - Seeking Alpha

Seeking Alpha - May 13, 2026

Judge Wolson Issues Key Summary Judgment Ruling on the Eve of Trial in the Arbutus v. Moderna mRNA Vaccine and Lipid Nanoparticle Case - JD Supra

JD Supra - Feb 05, 2026

Moderna to pay $950M to settle vaccine litigation with Arbutus, Genevant - FirstWord Pharma

FirstWord Pharma - Mar 04, 2026

Roivant, Arbutus Biopharma stocks surges on $2.25B Moderna settlement - Investing.com

Investing.com - Mar 03, 2026

Arbutus Biopharma Q1 revenue surges on Moderna settlement - TradingView

TradingView - May 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment